DNP Achieved Over 85% Repulpability for High Barrier Paper Mono-Material Sheet
Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) has successfully updated the materials and processing methods used in a proprietary mono-material sheet for packaging product to achieve over 85% repulpability1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240620532988/en/
Image of updated packaging employing paper mono-material sheet (Photo: Business Wire)
In 2022 we developed an environmentally friendly packaging sheet with high barrier properties2 that prevents the transmission of oxygen and water vapor as packaging materials for food, cosmetics, and medical products. At the same time, the use of mono-material paper facilitated increased recyclability.
Development
In recent years, as an indicator of eco-friendliness in the recyclability of paper packaging, efforts have been witnessed in Europe and the United States to improve the recycling effect of paper as a renewable resource, by increasing the repulpability to more than 80%.
In response to these challenges, DNP is putting efforts into expanding our line-up of eco-friendly packaging2. In this latest development, we have further improved the high barrier paper mono-material sheet for packaging, and will commence the provision of a revamped product with advanced recyclability that also maintains barrier-free features.
Going forward
DNP will provide high barrier paper mono-material sheet to manufacturers of food, cosmetics, and medical products. We will also leverage our proprietary converting technology, to expand our lineup of environmentally friendly products and services with enhanced barrier properties, and will deploy them in the global markets where demand for reducing environmental impact is growing.
The product will be exhibited at the DNP booth at INTERPHEX JAPAN 2024 to be held at Tokyo Big Sight from June 26 to 28, 2024.
1: The repulpability varies depending on the basis weight of the paper.
2: For further information about High Barrier Paper Mono-material Sheet for Packaging https://www.global.dnp/news/detail/20167671_4126.html
About DNP
DNP was established in 1876, and has become a leading global company that leverages print-based solutions and the strengths of its growing number of partners to engineer fresh business opportunities while protecting the environment and creating a more vibrant world for all. Today we develop and refine technologies for conducting electricity, controlling light and heat, decorating surfaces, and protecting content, effectively becoming a standard-setter for the industry of the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240620532988/en/
Contacts
Media contact
DNP
Yusuke Kitagawa
+81-3-6735-0101
kitagawa-y3@mail.dnp.co.jp
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sodali & Co Appoints Andrew Benett as Chief Executive Officer14.1.2025 10:00:00 CET | Press Release
Sodali & Co (the ‘firm’ or ‘Sodali’ and formerly Morrow Sodali), a leading global advisory firm, is pleased to announce the appointment of Andrew Benett as Chief Executive Officer, effective immediately. He will be based in New York. Andrew has a 30-year career across global advisory businesses including Global CEO and Chief Strategy Officer at Havas Creative Group, Chief Commercial Officer of Bloomberg Media and CEO and Executive Chair of Harte Hanks Inc., the NASDAQ-listed publishing company. Most recently, Andrew was a Partner at PwC working with clients to deliver organic and inorganic growth, as well as leading corporate strategy initiatives for the firm. He is an acknowledged strategist, author of three business books, and a fellow of the Aspen Institute. Andrew was appointed after a global search following Alvise Recchi stepping down as CEO last September. He joins the firm at an important moment in its development. In the last two years, Sodali has transformed at speed from a s
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology14.1.2025 10:00:00 CET | Press Release
Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114054102/en/ The company has been building momentum this year, assembling a world-class team, securing access to unique data sources, and successfully releasing its first model, H-Op
Cirium Ascend Consultancy Lands ‘Appraiser of the Year’ Title for the 10th Time14.1.2025 09:00:00 CET | Press Release
Cirium Ascend Consultancy, part of the world’s most trusted source of aviation analytics, Cirium, has once again landed Airline Economics’ prestigious title of ‘Appraiser of the Year’ at an award ceremony last night. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113971776/en/ Cirium awarded 'Appraiser of the Year' (Photo: Business Wire) This marks the tenth win for Cirium Ascend Consultancy, demonstrating its unparalleled expertise within aviation consultancy and underlining its unwavering commitment to excellence, transparency and accuracy. The annual award was presented to Rob Morris, Global Head of Cirium Ascend Consultancy, at the Airline Economics Aviation 100 Global Leaders Awards 2025 in Dublin, Ireland, which celebrates the best companies, individuals and transactions in the aviation finance and leasing sector. 2025’s landmark win makes it the first time a single firm has won the title 10 times, recognising Ciriu
Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth14.1.2025 07:00:00 CET | Press Release
Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook. The company’s CEO and president Carlos Gallardo will highlight a new era for its business starting in 2025 – forecasting sustained double-digit growth of net sales (CAGR 2023-2030) and a substantial margin expansion, driven by Almirall’s focus on medical dermatology, commercial excellence, and its continued investment in R&D to innovate and advance science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113044812/en/ Almirall HQ in Barcelona (Photo: Business Wire) Almirall combines the strengthening of its growth drivers, particularly the biologics products, with the continued growth of its broad portfolio of medical dermatology solutions, including Klisyri®, Wynzora®, and Seysara®. Almirall’s commercial excellence has been demons
Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss14.1.2025 07:00:00 CET | Press Release
Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weight loss with associated facial volume loss.1 Initial three-month interim data from this first-of-its-kind trial suggest that this treatment combination effectively improved facial aesthetic appearance with high patient satisfaction.1 The results will be presented later today at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Rates of medication-driven weight loss have increased rapidly in recent years and can be associated with facial alterations of variable magnitude.2-4 Patients can find that their skin is less radiant, drier or saggy, and can also observe changes in their facial structure and balance.3,4 Some even find that they appear older than their age.3,4 There are several reasons for these facial alterations including loss of fat, collagen, elastin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom